Semler Scientific, Inc. (SMLR) shares plummeted by 5.97% in Friday's pre-market trading session, significantly underperforming the broader market. The steep decline in the healthcare technology firm's stock was primarily attributed to the company's announcement of a $75 million private offering of convertible senior notes, which raised concerns about potential equity dilution.
The company disclosed its intention to offer the convertible notes due 2030 to institutional buyers, with an option to purchase up to an additional $15 million worth of notes. While the final terms are yet to be determined, Semler Scientific stated that it intends to use a portion of the proceeds to fund capped call transactions and for the acquisition of bitcoin, in line with its bitcoin treasury strategy.
Additionally, the company released preliminary fourth-quarter results, showing revenue expectations in the range of $12.1 million to $12.5 million. Although reflecting year-over-year growth, the revenue guidance may have fallen short of some analysts' projections, further exacerbating the negative sentiment surrounding the stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.